Blog
RSS FeedPosted by Michael Wonder on 14 Nov 2019
To drive down insulin prices, WHO will certify generic versions
13 November 2019 - About 80 million people with diabetes around the world need the hormone, and half of them can’t ...
Posted by Michael Wonder on 06 Nov 2019
One shot drug to end Sicilian curse comes at $1.8 million cost
5 November 2019 - A new targeted gene therapy shows the promise and pitfalls of medical advances. ...
Posted by Michael Wonder on 25 Oct 2019
Amgen to make Repatha (evolocumab) available exclusively at its lower list price option in 2020
24 October 2019 - Repatha original list price option will be discontinued effective 31 December 2019. ...
Posted by Michael Wonder on 23 Oct 2019
Vertex prices cystic fibrosis combo treatment at $311,000-per-year
22 October 2019 - Vertex Pharmaceuticals has priced its three-drug combination for cystic fibrosis (CF) at $311,503 per year, after winning ...
Posted by Michael Wonder on 17 Oct 2019
Pelosi’s drug pricing plan puts medical innovation at risk
17 October 2019 - The future of medical innovation in America is at a crossroads. ...
Posted by Michael Wonder on 11 Oct 2019
MSF demands Johnson & Johnson reduce price of life saving TB drug
11 October 2019 - Pharma company Johnson and Johnson sell TB drug bedaquiline for nearly US$1,200 per treatment course, a price ...
Posted by Michael Wonder on 11 Oct 2019
Pharma industry is 'right in the crosshairs,' Merck CEO Kenneth Frazier says
11 October 2019 - President Donald Trump and House Speaker Nancy Pelosi are in a battle over impeachment but their ...
Posted by Michael Wonder on 02 Oct 2019
The real impact of drug price legislation on biopharmaceutical R&D
2 October 2019 - As outcry around drug prices rages, arguments continue to surface that limiting corporate revenues via price controls ...
Posted by Michael Wonder on 02 Oct 2019
Trade agreement drug monopoly is obsolete given faster, better drug discovery
2 October 2019 - For decades, the brand-name drug industry has relentlessly promoted the message that any reduction in its ...
Posted by Michael Wonder on 23 Sep 2019
Novo prices oral Rybelsus on par with injectable rivals, ending discount fears
23 September 2019 - Monday morning, Bernstein analyst Wimal Kapadia echoed what many industry watchers were probably thinking about Novo ...
Posted by Michael Wonder on 09 Sep 2019
Novo Nordisk launching additional US insulin affordability offerings in January 2020
6 September 2019 - $99 Cash Card Program provides 3,000 - 3,600 units of any combination of Novo Nordisk analog insulins ...
Posted by Michael Wonder on 29 Aug 2019
Are reasonable restraints on drug price increases doomed by pharma lobbying?
29 August 2019 - In a rare but important display of congressional bipartisanship, Senators Chuck Grassley (R-Iowa) and Ron Wyden ...
Posted by Michael Wonder on 21 Aug 2019
Appealing court ruling, Trump administration renews fight to require drug prices in TV ads
21 August 2019 - The Trump administration isn’t giving up the fight to require drug makers include their sticker prices ...
Posted by Michael Wonder on 19 Aug 2019
AbbVie prices new rheumatoid arthritis drug at $59,000 a year
17 August 2019 - AbbVie has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on ...
Posted by Michael Wonder on 18 Aug 2019
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
17 August 2019 - Roche has priced its personalised cancer treatment, Rozlytrek, at about $17,050 per month, nearly half of ...